Atlas Trials

To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Metastatic Colorectal Cancer

Clinical trial NCT05673512 · UNKNOWN

Trial details

NCT number
NCT05673512
Sponsor
SUNHO(China)BioPharmaceutical CO., Ltd.
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
HER2 Gene Mutation
Start date
2023-05-12
Primary completion
2025-03-01
Enrollment
279

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.